288 related articles for article (PubMed ID: 19726941)
1. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
[TBL] [Abstract][Full Text] [Related]
2. Visual evoked potentials during hyperthermia.
Saul RF; Hayat G; Selhorst JB
J Neuroophthalmol; 1995 Jun; 15(2):70-8. PubMed ID: 7550932
[TBL] [Abstract][Full Text] [Related]
3. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
Alshuaib WB
Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
[TBL] [Abstract][Full Text] [Related]
4. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
[TBL] [Abstract][Full Text] [Related]
5. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation.
Gundogan FC; Demirkaya S; Sobaci G
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5773-81. PubMed ID: 18055831
[TBL] [Abstract][Full Text] [Related]
6. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
[TBL] [Abstract][Full Text] [Related]
7. Correlation between morphological and functional retinal impairment in multiple sclerosis patients.
Parisi V; Manni G; Spadaro M; Colacino G; Restuccia R; Marchi S; Bucci MG; Pierelli F
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2520-7. PubMed ID: 10509645
[TBL] [Abstract][Full Text] [Related]
8. [Spatial contrast sensitivity in multiple sclerosis].
Vighetto A; Grochowicki M; Cousin J
Rev Neurol (Paris); 1990; 146(4):264-70. PubMed ID: 2359900
[TBL] [Abstract][Full Text] [Related]
9. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
[TBL] [Abstract][Full Text] [Related]
11. Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
Gundogan FC; Tas A; Altun S; Oz O; Erdem U; Sobaci G
Indian J Ophthalmol; 2013 Mar; 61(3):100-3. PubMed ID: 23514643
[TBL] [Abstract][Full Text] [Related]
12. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.
Fisher JB; Jacobs DA; Markowitz CE; Galetta SL; Volpe NJ; Nano-Schiavi ML; Baier ML; Frohman EM; Winslow H; Frohman TC; Calabresi PA; Maguire MG; Cutter GR; Balcer LJ
Ophthalmology; 2006 Feb; 113(2):324-32. PubMed ID: 16406539
[TBL] [Abstract][Full Text] [Related]
13. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
[TBL] [Abstract][Full Text] [Related]
14. Pattern visual evoked potentials in the assessment of visual acuity in malingering.
Gundogan FC; Sobaci G; Bayer A
Ophthalmology; 2007 Dec; 114(12):2332-7. PubMed ID: 17618689
[TBL] [Abstract][Full Text] [Related]
15. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
[TBL] [Abstract][Full Text] [Related]
16. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous recording of pattern electroretinogram (PERG) and visual evoked potential (VEP) in multiple sclerosis.
Stefano E; Cupini LM; Rizzo P; Pierelli F; Rizzo PA
Acta Neurol Belg; 1991; 91(1):20-8. PubMed ID: 2028736
[TBL] [Abstract][Full Text] [Related]
18. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
Kolbe S; Chapman C; Nguyen T; Bajraszewski C; Johnston L; Kean M; Mitchell P; Paine M; Butzkueven H; Kilpatrick T; Egan G
Neuroimage; 2009 Apr; 45(3):679-86. PubMed ID: 19162205
[TBL] [Abstract][Full Text] [Related]
19. [Results of static perimetry in subclinical optic neuritis in multiple sclerosis].
Mauguière F; Perret-Magloire E
Rev Neurol (Paris); 1983; 139(12):745-52. PubMed ID: 6665389
[TBL] [Abstract][Full Text] [Related]
20. An analysis of VEP components in optic neuritis.
Andersson T; Sidén A
Electromyogr Clin Neurophysiol; 1995 Mar; 35(2):77-85. PubMed ID: 7781577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
